CD8A and neoplasm: In B16F10 tumor models, all three vaccine groups elicited elevated IFN-γ+ CD8+ T cell levels, with the CircB16-8 cohort showing the highest mean proportion: CircB16 (1.39%), LinearB16 (0.80%), and m1ΨLinearB16 (1.10%).